Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
Alla chiusura: 04:00PM EST
Preborsa:
| Chiusura precedente | 201,17 |
| Aperto | 201,38 |
| Denaro | 204,45 x 1100 |
| Lettera | 205,25 x 900 |
| Min-Max giorno | 200,84 - 203,80 |
| Intervallo di 52 settimane | 198,64 - 276,69 |
| Volume | |
| Media Volume | 2.775.960 |
| Capitalizzazione | 114,028B |
| Beta (5 anni mensile) | 0,62 |
| Rapporto PE (ttm) | 20,87 |
| EPS (ttm) | 9,70 |
| Prossima data utili | 31 gen 2022 - 04 feb 2022 |
| Rendimento e dividendo (forward) | 7,04 (3,48%) |
| Data ex dividendo | 15 nov 2021 |
| Stima target 1A | 240,48 |
- GlobeNewswire
BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors
NEW YORK and VANCOUVER, British Columbia, Nov. 02, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, is pleased to welcome the appointment of Jane Gross, Ph.D. to its Board of Directors. Dr. Jane Gross is a highly experienced biotech executive with over 30 years in leading research and development teams f
© 2021 Yahoo. Tutti i diritti riservati.
